Faguer, Stanislas <br/><br/>
Rituximab therapy for acute humoral rejection after kidney transplantation.  [electronic resource] 

 -  Transplantation  May 2007 
 - 1277-80 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/01.tp.0000261113.30757.d1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antibody Formation<br/>Creatine--blood<br/>Female<br/>Graft Rejection--blood<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Infections--etiology<br/>Isoantibodies--blood<br/>Kidney--physiopathology<br/>Kidney Failure, Chronic--etiology<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Pilot Projects<br/>Plasma Exchange<br/>Rituximab<br/>Steroids--therapeutic use<br/>Tacrolimus--therapeutic use<br/>Tissue Donors<br/>Treatment Outcome